Purification of Immunotoxin D2C7
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : Duke Medical Center
Other organizations : Duke University, University of Colorado Anschutz Medical Campus, Memorial Sloan Kettering Cancer Center, National Cancer Institute, National Institutes of Health, Center for Cancer Research
Variable analysis
- Expression of D2C7 in E. coli BL21 (λ DE3) under the control of T7 promoter
- Purity of the final D2C7 preparation (>95% by SDS-PAGE and size-exclusion chromatography (HPLC))
- Endotoxin removal from the purified immunotoxin (achieved with ActiClean Etox resin)
- Reduction, refolding, and purification of D2C7 from inclusion bodies as described previously (15)
- Positive control: Not explicitly mentioned.
- Negative control: Not explicitly mentioned.
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!